Please provide your email address to receive an email when new articles are posted on . This analysis focused on adults with moderate to severe COPD without an exacerbation during the ENHANCE trials.

Please provide your email address to receive an email when new articles are posted on . Across several subgroups, more patients receiving ensifentrine vs. placebo were classified as Transitional ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...

Novel, experimental treatment for emphysema may offer promising results for patients looking to breathe easier ...

More than 50% of adults with low pulmonary function are undiagnosed and unaware that they have COPD. Alpha-1 antitrypsin deficiency (AATD) is also a rare genetic disorder that causes COPD. 4 Alpha-1 ...

A common treatment for the breathlessness experienced by many people with chronic obstructive pulmonary disease (COPD) relies on the use of a positive-expiratory pressure (PEP) device, which sends ...

Pulmonary function tests are a group of noninvasive breathing tests that measure how much air your lungs can hold, how quickly you can move air in and out and how efficiently your lungs transfer ...

Poor sleep quality in PAH patients is linked to increased dyspnea and reduced exercise capacity, worsening disease burden. Severe dyspnea is a significant predictor of poor sleep quality, independent ...

A biologic injection that reduces chronic obstructive pulmonary disease (COPD) flare-ups by around a third has been approved for use on the NHS in England and Wales. The National Institute for Health ...